Evaluation of Topical B12 for the Treatment of Childhood Atopic Dermatitis
|ClinicalTrials.gov Identifier: NCT00465699|
Recruitment Status : Unknown
Verified April 2007 by Spartanburg Regional Family Medicine.
Recruitment status was: Recruiting
First Posted : April 25, 2007
Last Update Posted : April 25, 2007
|Condition or disease||Intervention/treatment||Phase|
|Eczema||Drug: Topical B12 0.07%||Not Applicable|
INTRODUCTION: Atopic dermatitis is a prevalent disease process in children, affecting up to 20% of children in the United States. Various treatment options are available to treat atopic dermatitis to include topical emollients, topical steroids, and topical calcineurin inhibitors. Each treatment option has benefits and potential risks. This study was done to determine if topical B12 could be a tolerable and efficacious alternative treatment option in this population.
METHODS: The study was conducted as a placebo-controlled, double-blind, prospective, randomized clinical trial with intraindividual left ⁄ right comparison. Parents were given 2 containers of creams and instructed to apply the Vitamin B12 cream to one side of the body and the placebo cream to the contralateral side according to the randomization scheme.
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||50 participants|
|Intervention Model:||Single Group Assignment|
|Official Title:||Evaluation of Topical B12 for the Treatment of Childhood Atopic Dermatitis|
|Study Start Date :||April 2007|
|Estimated Study Completion Date :||April 2007|
- Reduction in SCORAD at 2 and 4 weeks
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00465699
|Contact: Ronald P Januchowski, D.O.||firstname.lastname@example.org|
|Contact: Mary E Johnsonemail@example.com|
|United States, South Carolina|
|Center for Family Medicine||Recruiting|
|Spartanburg, South Carolina, United States, 29303|
|Principal Investigator: Ronald P Januchowski, D.O.|
|Principal Investigator:||Ronald P Januchowski, D.O.||Spartanburg Regional Family Medicine|